Hello, Fool! | Login | Signup | My Fool
Oct 13, 2008 6:47 PM ET | Feedback | Site Changes | Help
A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.
View All Commentary (DNDN)
Recs
BudandMolly (97.09) Submitted: 6/27/08 1:59 PM : Start Price: $4.52 DNDN Score: 28.28
This stock is stuck in a range until its long term trials are released. Near bottom of that range.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK